Paul D. Crowe

5.1k total citations
53 papers, 3.2k citations indexed

About

Paul D. Crowe is a scholar working on Immunology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Paul D. Crowe has authored 53 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 19 papers in Molecular Biology and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Paul D. Crowe's work include Stress Responses and Cortisol (13 papers), Immunotherapy and Immune Responses (10 papers) and Hormonal Regulation and Hypertension (8 papers). Paul D. Crowe is often cited by papers focused on Stress Responses and Cortisol (13 papers), Immunotherapy and Immune Responses (10 papers) and Hormonal Regulation and Hypertension (8 papers). Paul D. Crowe collaborates with scholars based in United States, Canada and Switzerland. Paul D. Crowe's co-authors include Carl F. Ware, Andy Neely, Chris Adams, Paul Conlon, Todd VanArsdale, Jeffrey L. Browning, Stefen A. Boehme, Dimitri E. Grigoriadis, David G. Alleva and Nicholas Ling and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Paul D. Crowe

53 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul D. Crowe United States	29	1.1k	887	395	376	374	53	3.2k
Katherine McGrath Australia	27	843 0.7×	566 0.6×	80 0.2×	635 1.7×	50 0.1×	76	3.4k
Bo Wu China	39	372 0.3×	2.4k 2.8×	172 0.4×	401 1.1×	104 0.3×	265	5.1k
Elizabeth Webster Australia	28	468 0.4×	205 0.2×	283 0.7×	85 0.2×	446 1.2×	133	3.0k
Marina Bianchi Italy	31	714 0.6×	849 1.0×	168 0.4×	319 0.8×	117 0.3×	92	3.6k
Benjamin M. Segal United States	51	4.0k 3.4×	1.1k 1.2×	43 0.1×	1.1k 2.9×	46 0.1×	149	8.1k
Jukka Luoma Finland	24	700 0.6×	770 0.9×	247 0.6×	136 0.4×	8 0.0×	57	3.1k
Kirsten Robertson Canada	21	176 0.2×	1.0k 1.2×	805 2.0×	417 1.1×	88 0.2×	38	3.8k
Jonathan M. Harris Australia	40	297 0.3×	1.9k 2.2×	387 1.0×	586 1.6×	21 0.1×	105	4.3k
Alok Kumar India	32	609 0.5×	1.4k 1.6×	42 0.1×	43 0.1×	57 0.2×	168	4.8k
Gilles Simard France	34	130 0.1×	1.3k 1.4×	266 0.7×	153 0.4×	23 0.1×	133	3.4k

Countries citing papers authored by Paul D. Crowe

Since Specialization

Citations

This map shows the geographic impact of Paul D. Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Crowe more than expected).

Fields of papers citing papers by Paul D. Crowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Crowe. The network helps show where Paul D. Crowe may publish in the future.

Co-authorship network of co-authors of Paul D. Crowe

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Crowe. A scholar is included among the top collaborators of Paul D. Crowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Crowe. Paul D. Crowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Babu, R. Satheesh, Jinghua Yu, Joe A. Tran, et al.. (2011). Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: Identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia. Bioorganic & Medicinal Chemistry Letters. 22(1). 421–426. 14 indexed citations

Moree, Wilna J., Fábio C. Tucci, Siobhan Malany, et al.. (2010). Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6. Bioorganic & Medicinal Chemistry Letters. 21(3). 947–951. 10 indexed citations

Babu, R. Satheesh, Jinghua Yu, Wilna J. Moree, et al.. (2010). The discovery and structure–activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia. Bioorganic & Medicinal Chemistry Letters. 20(9). 2916–2919. 35 indexed citations

Moree, Wilna J., Jinghua Yu, Fábio C. Tucci, et al.. (2010). Novel benzothiophene H1-antihistamines for the treatment of insomnia. Bioorganic & Medicinal Chemistry Letters. 20(7). 2316–2320. 14 indexed citations

Moree, Wilna J., Jinghua Yu, Siobhan Malany, et al.. (2010). Selectivity profiling of novel indene H1-antihistamines for the treatment of insomnia. Bioorganic & Medicinal Chemistry Letters. 20(8). 2629–2633. 11 indexed citations

Malany, Siobhan, Lisa M. Hernández, William F. Smith, Paul D. Crowe, & Sam R.J. Hoare. (2009). Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: Application to (R)-dimethindene occupancy of central histamine H₁receptors. Journal of Receptors and Signal Transduction. 29(2). 84–93. 25 indexed citations

Moree, Wilna J., Jinghua Yu, Mark Santos, et al.. (2009). Brain-penetrating 2-aminobenzimidazole H1-antihistamines for the treatment of insomnia. Bioorganic & Medicinal Chemistry Letters. 19(15). 4380–4384. 22 indexed citations

Hoare, Sam R.J., Beth A. Fleck, Raymond S. Gross, et al.. (2008). Allosteric Ligands for the Corticotropin Releasing Factor Type 1 Receptor Modulate Conformational States Involved in Receptor Activation. Molecular Pharmacology. 73(5). 1371–1380. 24 indexed citations

Fan, Jun, et al.. (2007). High-Throughput Screening for Norepinephrine Transporter Inhibitors Using the FLIPRTetra. SLAS DISCOVERY. 12(3). 436–441. 5 indexed citations

10.

Hoare, Sam R.J., Sue Sullivan, Nicholas Ling, Paul D. Crowe, & Dimitri E. Grigoriadis. (2003). Mechanism of Corticotropin-Releasing Factor Type I Receptor Regulation by Nonpeptide Antagonists. Molecular Pharmacology. 63(3). 751–765. 56 indexed citations

11.

Million, Mulugeta, Dimitri E. Grigoriadis, Sue Sullivan, et al.. (2003). A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Brain Research. 985(1). 32–42. 90 indexed citations

12.

Hoare, Sam R.J., Susan K. Sullivan, Anil Pahuja, et al.. (2003). Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands. Peptides. 24(12). 1881–1897. 23 indexed citations

13.

Alleva, David G., Paul D. Crowe, Liping Jin, et al.. (2001). A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. Journal of Clinical Investigation. 107(2). 173–180. 179 indexed citations

14.

Liu, Changlu, Xin-Jun Liu, Paul D. Crowe, et al.. (1999). Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation. Gene. 238(2). 471–478. 47 indexed citations

15.

Crowe, Paul D., Stefen A. Boehme, Amitabh Gaur, et al.. (1998). Differential signaling and hierarchical response thresholds induced by an immunodominant peptide of myelin basic protein and an altered peptide ligand in human T cells. Human Immunology. 59(11). 679–689. 9 indexed citations

16.

Kozovska, Milena, Ying C. Q. Zang, Víctor M. Rivera, et al.. (1998). T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications. European Journal of Immunology. 28(6). 1894–1901. 28 indexed citations

17.

Crowe, Paul D., et al.. (1995). A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes.. The Journal of Experimental Medicine. 181(3). 1205–1210. 213 indexed citations

18.

Ware, Carl F., Todd VanArsdale, Paul D. Crowe, & Jeffrey L. Browning. (1995). The Ligands and Receptors of the Lymphotoxin System. Current topics in microbiology and immunology. 198. 175–218. 218 indexed citations

19.

Crowe, Paul D., et al.. (1994). Production of lymphotoxin (LTα) and a soluble dimeric form of its receptor using the baculovirus expression system. Journal of Immunological Methods. 168(1). 79–89. 39 indexed citations

20.

Crowe, Paul D., et al.. (1991). Prolactin activates protein kinase C and stimulates growth-related gene expression in rat liver. Molecular and Cellular Endocrinology. 79(1-3). 29–35. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact